Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial-Reference-Cited by-全球学者库

Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial

Published:2014-11-10 Issue:1 Volume:15 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Qu Jianhui,Yu Zujiang,Li Qin,Chen Yongping,Xiang Dedong,Tan Lin,Lei Chunliang,Bai Wenlin,Li Hongyan,Shang Qinghua,Chen Liang,Hu Xiaoyu,Lu Wei,Li Zhiqin,Chen Da,Wang Xiaodong,Zhang Changjiang,Xiao Guangming,Qi Xun,Chen Jing,Zhou Li,Chen Guofeng,Li Yonggang,Zeng Zhen,Rong Guanghua,Dong Zheng,Chen Yan,Lou Min,Wang Chunping,Lu Yinying,Zhang Cuihong,Yang Yongping

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/1745-6215-15-438.pdf

Reference34 articles.

1. Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepatitis. 2004, 11: 97-107. 10.1046/j.1365-2893.2003.00487.x.

2. Zhao H, Si CW: Chinese epidemic status of viral hepatitis B. Chin J Front Med Sci. 2008, 1: 1-3. 10.7156/v1i1p001.

3. Zhang C, Zhong Y, Guo L: Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices. Biosci Trends. 2013, 7: 7-12.

4. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH, REVEAL-HBV Study Group: Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006, 295: 65-73. 10.1001/jama.295.1.65.

5. Fink SA, Jacobson IM: Managing patients with hepatitis-B related or hepatitis-C-related decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2011, 8: 285-295. 10.1038/nrgastro.2011.57.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis;Hepatology;2023-08-23

2. Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a;Biotechnology and Genetic Engineering Reviews;2023-04-14

3. Reply to: “Biejia-Ruangan compound and incidence of hepatocellular carcinoma”;Journal of Hepatology;2023-04

4. LncRNA MBNL1-AS1 knockdown increases the sensitivity of hepatocellular carcinoma to tripterine by regulating miR-708-5p-mediated glycolysis;Biotechnology and Genetic Engineering Reviews;2023-03-23

5. High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy;Journal of Gastroenterology;2023-03-16